ANTI-DYNAMIC LINE Test for Cream

NCT07067073 | Completed

• 1 other identifier: C24005075
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to find out whether a new cream (Formula# 899675 44A) can help reduce dynamic facial and neck wrinkles in young Chinese women. The main questions it aims to answer are:

• Does the cream lower the appearance of forehead wrinkles, crow's feet, under-eye wrinkles, and nasolabial folds when participants smile or raise their eyebrows?
• Does the cream help reduce horizontal neck folds when participants lower their heads? About 45 healthy women between the ages of 18 and 35 will take part in this 10-week study. They will:
• Stop using other anti-aging products for 2 weeks (wash-out period)
• Apply the study cream on their face and neck twice a day for 8 weeks
• Visit the clinic 4 times for facial and neck photo collection and clinical assessments
• Learn to make standard facial expressions for photo comparisons Researchers will compare wrinkle changes using dermatologist scores and photo grading at different time points.

Conditions

Dynamic Wrinkles

Outcome Measures

Primary Outcomes (1)

• Time effect of facial and neck wrinkles (Dermatologist-assessed)

  Clinical scoring of dynamic wrinkles in five facial and neck areas: forehead wrinkles (raising eyebrow), crow's feet wrinkles, underneath eye wrinkles, nasolabial folds (smiling), and horizontal neck folds (lowering head), as assessed by dermatologist at T0, T4wk, and T8wk using the Skin Aging Atlas. Assessment is based on facial expression photos and in-person evaluation. Wilcoxon Signed Rank Test will be used to analyze changes from baseline.

  Baseline (T0) to Week 8 (T8wk)

Secondary Outcomes (3)

• Time effect of facial wrinkles (Expression image-based)

  Baseline (T0) to Week 8 (T8wk)

• Time effect of adverse events and intolerance reactions

  Baseline (T0) to Week 8 (T8wk)

• Time effect of product compliance (Twice-daily usage)

  Baseline (T0) to Week 8 (T8wk)

Study Arms (1)

Investigational Cream Arm

EXPERIMENTAL

Participants apply the investigational cream (Formula# 899675 44A) on the entire face and neck twice daily for 8 weeks following a 2-week wash-out period. Application is supervised on-site at baseline and self-administered at home thereafter. Clinical assessments and facial/neck image capture are conducted at baseline, week 4, and week 8.

Other: Anti-Dynamic Line Cream

Interventions

Anti-Dynamic Line Cream OTHER

Topical cream (Formula# 899675 44A) applied to the full face and neck twice daily for 8 weeks. Participants apply 1 g each time in the morning and evening after cleansing, with massage on wrinkle-prone areas. Used after a 2-week wash-out period with standard skincare.

Investigational Cream Arm

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Chinese female aged 18-35 years old.
• All skin types will be contained, including 50% sensitive skin.
• Regular users of cleanser, anti-aging cream and sunscreen product.
• Self-claim having concerns of wrinkles problems.
• Presenting with obvious dynamic wrinkles while making smiling/raising eyebrow expression ( expression reach max condition) evaluated by Dermatologist：
• Raise eyebrow: Forehead wrinkles (Loreal Atlas, 1\<grade≤4)
• Smile: Underneath eye wrinkles (Loreal Atlas, grade≥3)
• Smile: Crow's feet wrinkles (Loreal Atlas, grade≥3)
• Smile: Nasolabial folds (Loreal Atlas, grade\>1)
• Did not participate in any clinical test or cosmetic product test on skin within 3 months.
• Did not participate any chemical procedures for previous 2 months; and willing to not participate any procedures during the whole study.
• No disagreement of dermatologist because of other reasons that exclude the participation of the Subject.
• In general, good health at the time of the study.
• Willing and able to participate as evidenced by signing of informed consent and photorelease form.
• Must be willing to comply with all study protocol requirements (pay attention to not take topical or oral treatment like retinol, hormone, antioxidant health-care products which may affect the efficacy of test products).

You may not qualify if:

• Intending to get pregnant, pregnant, lactating or within 6 months of delivery.
• Subject deprived of rights by a court or administrative order.
• Major subject to a guardianship order.
• Subject residing in a health or social care establishment.
• Patient in an emergency setting.
• Subject with a skin disease in the test areas (particularly e.g., acne, rosacea, eczema).
• Subject presenting a stable or progressive serious disease (per investigator's assessment).
• Immuno-compromised subject.
• Subject with history of allergy to cosmetic or personal care products or ingredients.
• Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
• Subjects regularly practicing aquatic or nautical sports.
• Subjects regularly attending a sauna.
• Subject with cardiovascular or circulatory history.
• Subject with a history of skin cancer or malignant melanoma.
• Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study

Sponsors & Collaborators

• ChinaNorm: lead

Study Sites (1)

Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072

Shanghai, China

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 4, 2025
• First Posted: July 15, 2025
• Study Start: October 29, 2024
• Primary Completion: December 24, 2024
• Study Completion: January 12, 2025
• Last Updated: July 15, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
• Time Frame: 18-Month Duration: The data sharing period starts upon study completion and PRS registration completion. Timeline: Months 2-3: Data de-identification, metadata preparation, and platform integration. Month 4: Official launch of data access.
• Access Criteria: Primary Platform: ResMan (www.medresman.org.cn) - China's leading medical research data repository. Eligibility: Researchers/affiliates from academic institutions, hospitals, or registered research organizations. Engaged in dermatology, cosmetic science, or related fields. Able to demonstrate ethical compliance and data security capabilities.

Locations

CN (1)